摘要
血管重建术后再狭窄的发生率较高 ,至今仍是一个临床难题。在血管损伤后再狭窄的过程中 ,纤溶酶原激活物 /纤溶酶系统尤其是尿激酶型纤溶酶原激活物及其受体起着非常重要的作用。
出处
《国外医学（外科学分册）》
2005年第2期149-153,共5页
Foreign Medical Sciences(section of Surgery)
基金
国家自然科学基金资助项目 ( 3 0 471688)
上海市科委重点资助项目 ( 0 0 41190 2 2)
参考文献26
-
1Harrell RL, Rajanayagam S. Inhibition of vascular smooth muscle cell proliferation and neointimal accumulation by adenovirus-mediated gene transfer of cytosine deaminase. Circulation, 1997; 96(2) :621 - 627.
-
2Bauters C, Isner JM. The biology of restenosis. Prog Cardiovasc Dis, 1997; 40(2): 107-116.
-
3Schwartz RS. Patheophysiology of resterosis: interactive of thrombosis, hyperplasia and/or remodeling. Am J Carcliol, 1998; 81:14E - 17E.
-
4Dumler I. Urokinase induces activation and formation of Stat4 and Statl-Stat2 complexes in human vascular smooth muscle cells. J Biol Chem, 1999; 274: 24059-24065.
-
5Lijnen HR, CoHen D. Matrix metalloproteinase system deficiencies and matrix degradation. Thromb Haemst, 1999; 82: 837-845.
-
6Christ G, Kosmer K. Plasmin activation system in restenosis: role in pathogenesis and clinical prediction? J Thromb Thrombolysis.1999; 7(3): 277-285.
-
7Plekhanova OS, Parfyonova YV. Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries. J Hypertens, 2000; 18(8): 1065-1069.
-
8Kienast J, Padr6 T. Expression of urokinase-type plasminogen activator in atheroselerotic coronary arteries from human heart explants. Thromb Haemost, 1998; 79: 579-586.
-
9Plekhanova O. Urokinase plasminogen activator augments cell proliferation and neointima fomation in iniured arteries via protolytic mechanisms. Atherosclerosis, 2001; 159: 297-306.
-
10Sandip M. Kanse induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders. Arteriosclerosis Thromb Vase Biol, 1997; 17: 2848-2854.
同被引文献15
-
1Pyke C, IG-istensen P, Ralfkiaer E, et al. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas [J]. Am J Pathol, 1991, 138 (5) : 1 059-1 067.
-
2Lijnen HR. Elements of the fibrinolytic system. Ann N Y Acad Sci, 2001, 936 : 226-236.
-
3Sidenius N, Blasi F. The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy[ J]. Cromer Metastasis Rev. 2003,22(2-3) : 205-222.
-
4Choong PF, Nadesapillai AP. Urokinase plasminogen activator system: amultifunctional role in tumor progression and metastasis [ J]. Clin Orthop Relat Res. 2003, (415 Suppl) : S46-S58.
-
5Shariat SF, Roehrbom CG, McConnell JD, et al. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastais [J]. J Clin Oncol.2007,25(4) :349-355.
-
6Plesner T, Behrendt N, Ploug M. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, u-PAR. Stem Cells. 1997,15(6) : 398-408.
-
7Hosomi N, Lucero J, Heo JH, et al. Rapid differential endogenous plasminogen activator Expression after acute middle cerebral artery occlusion [J]. Stroke,2001,32(6) : 1 341-1 348.
-
8Chang DI, Hosomi N, Lucero JH, et al. Activation Systems for Latent Matrix Metallopoteinase-2 are upregulated immediately after focal cerebral ischemia[J] .J Cereb Blood Flow Metab,2003,23(12) : 1 408- 1 419.
-
9Li C, Zhang J, Jiang Y, et al. Urokinase-type plasminogen activator upregulates its own expression by endothelial cells and monocytes via the u- PAR pathway[J]. Thromb Res,2001,103(3) :221-232.
-
10Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis [ J]. Cell Mol Life Sci, 2000,57(1) :25-40.
-
1陈康玉,严激.冠状动脉支架内再狭窄的炎症机制和抗炎治疗[J].心血管康复医学杂志,2009,18(1):88-90. 被引量：2
-
2黎娜,朱文玲,柯元南.动脉粥样硬化与组织因子[J].心血管病学进展,2006,27(6):770-772. 被引量：2
-
3梁翠格,于桂娜.PAI-1与糖尿病肾病相关性研究[J].山东医药,2005,45(7):68-69. 被引量：2
-
4张冬梅,顾华,孙广东,苗里宁,刘建东.甲基强的松龙对狼疮性肾炎患者血浆中PAI-1的影响[J].中国免疫学杂志,2003,19(5):355-356. 被引量：1
-
5于占彩,李振光.凝血酶在动脉血栓形成及血管损伤中的作用[J].国外医学（老年医学分册）,1998,19(5):202-204.
-
6王婉玉,陈玉珍,姜亚香.24例急性早幼粒细胞性白血病合并弥漫性血管内凝血的护理[J].医学理论与实践,2005,18(9):1081-1082.
-
7马林,丁彦春,崔晓琼,姜华,王虹艳,曲鹏.Toll样受体4—核因子κB信号通路在血管成形术后再狭窄过程中的作用[J].中国动脉硬化杂志,2006,14(7):596-600. 被引量：6
-
8柯文志,浦晓东.PTEN及其在血管成形术后再狭窄中作用的研究进展[J].福建医药杂志,2008,30(1):95-97. 被引量：1
-
9李东宝,沈潞华,谢苗荣.动脉粥样硬化和再狭窄中平滑肌细胞凋亡[J].中国动脉硬化杂志,2000,8(3):276-278. 被引量：3
-
10田孝祥.冠脉裸金属支架植入术后口服雷帕霉素预防再狭窄:阿根廷的前瞻性、随机的口服雷帕霉素(ORARⅡ)研究[J].中国实用内科杂志：临床前沿版,2006,26(8):1296-1296.
